1 / 5

21 CFR Part 210 | 211 Quality Assurance | Operon Strategist

Operon Strategist helps in maintaining compliance with 21 CFR Part 210 and 21 CFR Part 211 which is critical to the pharmaceutical industry<br>Contact details u2013 <br>Phone no - 9325283428<br>Mail - dm@operonstrategist.com<br>Visit - https://www.operonstrategist.com/21-cfr-part-210-211/?utm_source=ppt & pdf submission&utm_medium=ppt & pdf page&utm_campaign=ppt & pdf submission<br>

operon
Download Presentation

21 CFR Part 210 | 211 Quality Assurance | Operon Strategist

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. 21 CFR PART 210 | 21 CFR PART 211 QUALITY ASSURANCE

  2. In the 21 CFR Part 210 and 211, 21 CFR Part 210 deals with the Manufacturing, Processing, Packaging or Holding of drugs, while 21 CFR Part 211 deals with finished pharmaceuticals. This cGMP Guidance related to the pharmaceutical and drug-related industry. 21 CFR Part 210 and 211 The move was in response to concerns about substandard drug manufacturing practices at the time. The 1962 Drug modification brought modern quality assurance and control principles to drug manufacturing. The word “current” was later added to make it “CGMP” (or cGMP) to imply that the regulation allows for changing technology in attaining GMP.

  3. 21 CFR Part 210 and 21 CFR Part 211 Current Good Manufacturing Practice for Finished PharmaceuticalsSubpartA-General Provisions. Subpart B–Organization and Personnel. Subpart C–Buildings and Facilities. Subpart D–Equipment. Subpart E–Control of Components and Drug Product Containers and Closures. Subpart F–Production and Process Controls. Subpart G– Packaging and LabelingControl Subpart H–Distribution and Holding. Subpart I–Laboratory Controls. Subpart J–Reports and Records. Subpart K–Returned and Salvaged Drug Products.

  4. Operon Strategist helps in maintaining compliance with 21 CFR Part 210 and 21 CFR Part 211 which is critical to the pharmaceutical industry. This includes observation ofcurrent good manufacturing practice (cGMP) by understanding and planning the processes and methods defined in FDA Guidelines. We also help in the development of training modules for comprehension to various parts of the regulations, and also in the guide in strategic review and assessment of the organization for personal optimization. We also help our client In-depth system auditsand recommendations for improvements, site inspection preparation activities and mock inspections.

  5. Thank You. For More Information Contact Us info@operonstrategist.com www.operonstrategist.com Call / Whatsapp - 9325283428

More Related